Sangeeta N. Bhatia is a cancer researcher, Massachusetts Institute of Technology professor and biotech entrepreneur who adapts technologies developed in the computer industry for medical innovation. Among her team’s inventions are microlivers that model diseases of the liver, synthetic biomarkers for noninvasive disease monitoring, and living medical devices to support patients with organ failure.
Dr. Bhatia holds an M.D. from Harvard Medical School, a Ph.D. from MIT, and a Bachelor’s degree from Brown University. At MIT, she is the John J. and Dorothy Wilson Professor at the Institute for Medical Engineering and Science and Electrical Engineering and Computer Science, inaugural director of the Marble Center for Cancer Nanomedicine and a member of the Ludwig Center for Molecular Oncology – both part of the Koch Institute for Integrative Cancer Research at MIT. Bhatia is also a Howard Hughes Medical Institute investigator, on the Board of Directors at Vertex Pharmaceuticals, and an elected member of the National Academy of Science, the National Academy of Medicine, the National Academy of Engineering, and Brown University’s Board of Trustees.
Dr. Bhatia has been honored with the Lemelson-MIT Prize for her research contributions, and the Heinz Medal for groundbreaking inventions and advocacy for women in STEM fields. She has presented her vision for the application of engineering solutions to solve medical problems on international stages such as the World Economic Forum, TED, the Gates Grand Challenges, and the Biden Cancer Moonshot.